drugset / Trial / NCT01968226

TRACER RGD-K5 Carotid Plaque Imaging Study

NCT01968226 ↗

Phase 2 Terminated 3 enrolled The Cleveland Clinic
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to investigate the ability of the compound\[F-18\]RGD-K5, when used as a tracer during PET (positron emission tomography) imaging, to detect regions of unstable atherosclerotic plaque in the carotid artery of subjects being considered for carotid endarterectomy (CEA),and to confirm this ability through histological studies of samples of carotid artery plaques that will be collected during the planned carotid surgery.

Timeline

Start
2013-11
Primary completion
2016-06
Completion
2016-06

Outcome

Outcome not reported

Stopped: “Investigator left instititution”

Drugs

EvaluationDrugModalityDoseRoute
Subject [F-18]RDG-K5 Diagnostic / imaging agent — Intravenous

Indications